 ENCINITAS, Calif., Nov. 19, 2021 GLOBE NEWSWIRE -- Ventyx Biosciences, Inc. Nasdaq: VTYX, Ventyx or the Company, a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders, announced today that Raju Mohan, Chief Executive Officer of Ventyx, will provide a company overview at the following upcoming investor conferences: 